• About
  • Licensing
  • Podcasting
  • Contact

AudioMedica.com

Medical News Interviews

  • Public Health
  • Oncology
  • Cardiovascular
  • General Medicine

New Drug RAD001 Plus Letrozole In Neoadjuvant Therapy For Breast Cancer

0
  • by alexperjescuadmin
  • in Oncology
  • — 15 Dec, 2007
New Drug RAD001 Plus Letrozole In Neoadjuvant Therapy For Breast Cancer
AudioMedica News
New Drug RAD001 Plus Letrozole In Neoadjuvant Therapy For Breast Cancer
New Drug RAD001 Plus Letrozole In Neoadjuvant Therapy For Breast Cancer
00:00 /
RSS Feed
Share
Link
Embed
//-->//>' class="input-embed input-embed-393"/>
Jose Baselga
Jose Baselga

JOSE BASELGA, Vall d’Hebron Hospital, Barcelona
RAD001, a drug targeted at the mTor pathway, has been combined with letrozole in a randomised phase II trial in breast cancer. The investigators saw more responses in the experimental arm, and so Derek Thorne got the details from Jose Baselga of Vall d’Hebron Hospital in Barcelona.

New Drug RAD001 Plus Letrozole In Neoadjuvant Therapy For Breast Cancer



LISTEN

[audio:https://www.audiomedica.com/podcasting/oncology/071214_jose_baselga.mp3]

Share

Tags: breastbreast-cancercancerdrugdrugsexperimental armhospital barcelonainvestigationmp3Oncologypodcastpodcastingtherapiestherapythornetrial

You may also like...

  • First effective treatment for “orphan disease’: Anti I/L 6 antibody brings remissions in Multicentric Castleman's Disease First effective treatment for “orphan disease’: Anti I/L 6 antibody brings remissions in Multicentric Castleman’s Disease 21 Jan, 2014
  • Jonathan Peled, New York Microbiome Diversity Key To Survival After Allogeneic Hematopoietic Cell Transplantation 14 Jan, 2020
  • Enzalutamide improves overall and progression-free survival in men with chemotherapy-naïve metastatic castration-resistant prostate cancer Enzalutamide improves overall and progression-free survival in men with chemotherapy-naïve metastatic castration-resistant prostate cancer 6 Mar, 2014
  • "Promising Activity" Of Cetuximab In Patients With Advanced Biliary Cancer “Promising Activity” Of Cetuximab In Patients With Advanced Biliary Cancer 8 Aug, 2009

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

  • Previous story AACR In New Partnership For San Antonio Breast Cancer Symposium
  • Next story ATAC Trial: Anastrozole Still Superior At Over Eight Years’ Follow Up
  • News

    • Mandeep Mehra MDCOVID-19 Co-Morbidity Risks Quantified from Three Continents SurveyMay 28, 2020
    • Ultrahypofractionated Radiation Just As Effective for Prostate CancerUltrahypofractionated Radiation Just As Effective for Prostate CancerMay 16, 2018
    • Paracetamol Poisoning: 12-hour modified acetylcysteine treatment for paracetamol poisoning reduced side effects associated with standard regimen.First evidence that genome editing made patients with AIDS more resistant to HIVMarch 8, 2014
    • Paracetamol Poisoning: 12-hour modified acetylcysteine treatment for paracetamol poisoning reduced side effects associated with standard regimen.Anticoagulation with warfarin can be beneficial in patients with atrial fibrillation and chronic kidney disease.March 7, 2014
    • Paracetamol Poisoning: 12-hour modified acetylcysteine treatment for paracetamol poisoning reduced side effects associated with standard regimen.Prostate cancer: Adult exposure to bisphenol-A linked to prostate cancer riskMarch 6, 2014
  • Related interviews

    • Ibrutinib: New Frontline Standard for Chronic…
    • New Front Line Standard for Older Patients with…
    • Microbiome Diversity Key To Survival After…
    • Genomic-led AML Clinical Decision Making Within Seven Days
    • Long Overall Survival in Ceritinib-Treated…
  • Home
  • Oncology
  • New Drug RAD001 Plus Letrozole In Neoadjuvant Therapy For Breast Cancer

© Copyright 2021 AudioMedica.com. Typegrid Theme by WPBandit.